Actinium Appoints Lynn Bodarky as Chief Business Officer

Senior leader with proven track record of executing business development and licensing transactions totaling $5 billion at multinational pharmaceutical and biotechnology companies NEW YORK, Nov. 3, 2023 -- (Healthcare Sales & Marketing Network) -- Acti... Biopharmaceuticals, Oncology, Personnel Actinium Pharmaceuticals, Iomab-B, targeted radiotherapies, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news